{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:50:10Z","timestamp":1764784210536,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00417-019-04348-5","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T01:09:19Z","timestamp":1557882559000},"page":"1453-1458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients"],"prefix":"10.1007","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9747-8312","authenticated-orcid":false,"given":"Vanessa","family":"Waisberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Oswaldo Carneiro","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio Bittar","family":"Nehemy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Bastos-Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Marques","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"4348_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.7326\/0003-4819-113-1-39","volume":"113","author":"NIH conference statement","year":"1990","unstructured":"NIH conference statement (1990) Neurofibromatosis 1 (von Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Intern Med 113:39\u201352","journal-title":"Ann Intern Med"},{"key":"4348_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0092-8674(87)90534-4","volume":"49","author":"BR Seizinger","year":"1987","unstructured":"Seizinger BR, Rouleau GA, Ozelius LJ et al (1987) Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 49:589\u2013594","journal-title":"Cell"},{"key":"4348_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/329246a0","volume":"329","author":"G Roleau","year":"1987","unstructured":"Roleau G, Seizinger BR, Ozelius LG et al (1987) Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246\u2013248","journal-title":"Nature"},{"key":"4348_CR4","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","volume":"16","author":"J Cooper","year":"2014","unstructured":"Cooper J, Giancotti FG (2014) Molecular insights into NF2\/Merlin tumor suppressor function. FEBS Lett 16:2743\u20132752","journal-title":"FEBS Lett"},{"key":"4348_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/0004-282X20130241","volume":"72","author":"LO Rodrigues","year":"2014","unstructured":"Rodrigues LO, Batista PB, Goloni-Bertollo EM et al (2014) Neurofibromatosis part 1 \u2013 diagnosis and differential diagnosis. Arq Neuropsiquiatr 72:241\u2013250","journal-title":"Arq Neuropsiquiatr"},{"key":"4348_CR6","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jmg.2004.029504","volume":"42","author":"ME Basser","year":"2005","unstructured":"Basser ME, Kuramoto L, Woods R et al (2005) The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet 42:540\u2013546","journal-title":"J Med Genet"},{"key":"4348_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C et al (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet 152A:327\u2013332","journal-title":"Am J Med Genet"},{"key":"4348_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1212\/WNL.54.1.71","volume":"54","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sankila R, Carp\u00e9n O, Pukkala E, Sainio M, J\u00e4\u00e4skel\u00e4inen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71\u201376","journal-title":"Neurology"},{"key":"4348_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DGR Evans","year":"2009","unstructured":"Evans DGR (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16","journal-title":"Orphanet J Rare Dis"},{"key":"4348_CR10","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/archopht.126.10.1376","volume":"126","author":"M Feucht","year":"2008","unstructured":"Feucht M, Kluwe L, Mautner VF, Richard G (2008) Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2. Arch Ophthalmol 126:1376\u20131380","journal-title":"Arch Ophthalmol"},{"key":"4348_CR11","first-page":"529","volume":"59","author":"DM Parry","year":"1996","unstructured":"Parry DM, MacCollin MM, Kaiser-Kupfer MI et al (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet 59:529\u2013539","journal-title":"Am J Hum Genet"},{"key":"4348_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.devcel.2017.11.011","volume":"44","author":"KH Moon","year":"2018","unstructured":"Moon KH, Kim HT, Lee D, Rao MB, Levine EM, Lim DS, Kim JW (2018) Differential expression of NF2 in neuroepithelial compartments is necessary for mammalian eye development. Dev Cell 44:13\u201328","journal-title":"Dev Cell"},{"key":"4348_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0161-6420(92)31789-0","volume":"99","author":"LD Kaye","year":"1992","unstructured":"Kaye LD, Rothner AD, Beauchamp GR, Meyers SM, Estes ML (1992) Ocular findings associated with neurofibromatosis type II. Ophthalmology 99:1424\u20131429","journal-title":"Ophthalmology"},{"key":"4348_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","volume":"141","author":"MM Bosch","year":"2006","unstructured":"Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and a long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141:1068\u20131077","journal-title":"Am J Ophthalmol"},{"key":"4348_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1600-0420.2007.01088.x","volume":"86","author":"M Feucht","year":"2008","unstructured":"Feucht M, Griffiths B, Niem\u00fcller I, Haase W, Richard G, Mautner VF (2008) Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders. Acta Ophthalmol 86:882\u2013886","journal-title":"Acta Ophthalmol"},{"key":"4348_CR16","doi-asserted-by":"publisher","first-page":"OCT262","DOI":"10.1167\/iovs.15-18919","volume":"57","author":"V Waisberg","year":"2016","unstructured":"Waisberg V, Rodrigues LO, Nehemy MB, Frassom M, De Miranda DM (2016) Spectral-domain optical coherence tomography findings in neurofibromatosis type 2. Inves Ophthalmol Vis Sci 57:OCT262\u2013OCT267","journal-title":"Inves Ophthalmol Vis Sci"},{"issue":"13","key":"4348_CR17","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede T (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31(13):3381\u20133385","journal-title":"Nucleic Acids Res"},{"key":"4348_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.20393","volume":"28","author":"I Ahronowitz","year":"2007","unstructured":"Ahronowitz I, Xin W, Kiely R, Sims K, Maccollin M, Nunes FP (2007) Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 28:1\u201312","journal-title":"Hum Mutat"},{"key":"4348_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jmg.40.2.109","volume":"40","author":"L Kluwe","year":"2003","unstructured":"Kluwe L, Mautner V, Heinrich B et al (2003) Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109\u2013114","journal-title":"J Med Genet"},{"key":"4348_CR20","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/hmg\/7.13.2051","volume":"7","author":"L Kluwe","year":"1998","unstructured":"Kluwe L, Mautner VF (1998) Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:2051\u20132055","journal-title":"Hum Mol Genet"},{"key":"4348_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/path.1174","volume":"198","author":"C Chan","year":"2002","unstructured":"Chan C, Koch CA, Kaiser-Kupfer MI et al (2002) Loss of heterozygosity for the NF gene in retinal and optic nerve lesions of patients with neurofibromatosis 2. J Pathol 198:14\u201320","journal-title":"J Pathol"},{"key":"4348_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","volume":"119","author":"F Viola","year":"2012","unstructured":"Viola F, Villani E, Natacci F et al (2012) Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology 119:369\u2013375","journal-title":"Ophthalmology"},{"key":"4348_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00417-017-3870-z","volume":"256","author":"A Moramarco","year":"2018","unstructured":"Moramarco A, Giustini S, Nofroni I, Mallone F, Miraglia E, Lacovino C, Calvieri S, Lambiase A (2018) Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol 256:307\u2013311","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4348_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/bjo.77.10.646","volume":"77","author":"K Landau","year":"1993","unstructured":"Landau K, Yasargil GM (1993) Ocular fundus in neurofibromatosis type 2. Br J Ophthalmol 77:646\u2013649","journal-title":"Br J Ophthalmol"},{"key":"4348_CR25","first-page":"245","volume":"93","author":"SM Meyers","year":"1995","unstructured":"Meyers SM, Gutman FA, Kaye LD, Rothner AD (1995) Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 93:245\u2013257","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4348_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/IAE.0b013e3181dc58bf","volume":"30","author":"RA Sisk","year":"2010","unstructured":"Sisk RA, Berrocal AM, Schefler AC, Dubovy SR, Bauer MS (2010) Epirretinal membranes indicate a severe phenotype of neurofibromatosis type 2. Retina 30:51\u201358","journal-title":"Retina"},{"key":"4348_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archopht.125.3.389","volume":"125","author":"ME McLaughlin","year":"2007","unstructured":"McLaughlin ME, Pepin SM, MacCollin MM, Choopong P, Lessell S (2007) Ocular pathologic findings of neurofibromatosis type 2. Arch Ophthalmol 125:389\u2013394","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04348-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04348-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:21:25Z","timestamp":1589412085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04348-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4348"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04348-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.All procedures performed in the study involving human participants were in accordance with ethical standards of the institutional committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}